162 related articles for article (PubMed ID: 12821085)
1. [Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy].
Slim K; Le Borgne J
Ann Chir; 2003 Apr; 128(3):175-6. PubMed ID: 12821085
[No Abstract] [Full Text] [Related]
2. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
[TBL] [Abstract][Full Text] [Related]
3. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
Angst E; Gloor B
Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
[No Abstract] [Full Text] [Related]
4. [Pancreaticojejunal anastomosis: the "Achilles heel" of pancreaticoduodenectomy].
Gulbinas A; Barauskas G; Pundzius J
Medicina (Kaunas); 2004; 40(10):927-34. PubMed ID: 15516814
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.
Fernández-Cruz L; Jiménez Chavarría E; Taurà P; Closa D; Boado MA; Ferrer J
HPB (Oxford); 2013 May; 15(5):392-9. PubMed ID: 23557411
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
[TBL] [Abstract][Full Text] [Related]
7. Comment on the article by Droeser et al.: 'Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery'.
Büchler MW
Dig Surg; 2013; 30(4-6):328-9. PubMed ID: 24051517
[No Abstract] [Full Text] [Related]
8. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas].
Brunaud L; Sebbag H; Marchal F; Verdier A; Bresler L; Tortuyaux JM; Boissel P
Ann Chir; 2001 Feb; 126(1):34-41. PubMed ID: 11255969
[TBL] [Abstract][Full Text] [Related]
9. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
[TBL] [Abstract][Full Text] [Related]
11. Mean--and the reporting of continuous data.
Søreide JA
Dig Surg; 2013; 30(4-6):330. PubMed ID: 24030358
[No Abstract] [Full Text] [Related]
12. Prevention, evaluation, and treatment of leaks after gastrointestinal surgery : prevention of leaks after pancreatic surgery.
Lillemoe KD
J Gastrointest Surg; 2011 Aug; 15(8):1325-6. PubMed ID: 21633869
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of pancreatic fistula after pancreatoduodenectomy].
Kriger AG; Gorin DS; Kaldarov AR; Galkin GV
Khirurgiia (Mosk); 2020; (11):61-65. PubMed ID: 33210509
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
You DD; Paik KY; Park IY; Yoo YK
Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
Li-Ling J; Irving M
Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
[TBL] [Abstract][Full Text] [Related]
16. The pancreatic stump after pancreatoduodenectomy: the "Achille's heel" revisited..
Paye F
J Visc Surg; 2010 Feb; 147(1):e13-20. PubMed ID: 20587374
[TBL] [Abstract][Full Text] [Related]
17. [Use of lanreotide in the prevention of pancreatic fistula after cephalic duodeno-pancreatectomy. Preliminary study].
Slim K; Buc E; Lescure G; Chanudet M; Pezet D; Chipponi J
Chirurgie; 1999 Dec; 124(6):661-5. PubMed ID: 10676028
[TBL] [Abstract][Full Text] [Related]
18. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
Lai EC; Lau SH; Lau WY
Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
[TBL] [Abstract][Full Text] [Related]
19. Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.
Young S; Sung ML; Lee JA; DiFronzo LA; O'Connor VV
HPB (Oxford); 2018 Sep; 20(9):834-840. PubMed ID: 30060910
[TBL] [Abstract][Full Text] [Related]
20. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
